Introduction
Opiate maintenance treatment (OMT) for heroin-addicted persons started in the 1990s in Germany and the number of treated persons has increased continuously. In 2011, 76,200 patients took part in German OMT programs. The total number of opioid users receiving substitution treatment in Europe is estimated to be 730,000. Methadone is the most commonly prescribed medication given to up to three quarters of the clients, while buprenorphine is prescribed to most of the remaining clients (1) . Substitution with either methadone or buprenorphine provides heroin-addicted patients with an opportunity to recover from opiate addiction. In Germany, the patients are medicated with racemic methadone, levomethadone or buprenorphine. Methadone is prescribed in most of the cases (54.8%), followed by levomethadone (25.4%) and buprenorphine (19.2 %) (2). Substitutes have to be taken orally each day under the surveillance of a physician or a pharmacist to avoid the occurrence of withdrawal symptoms. In 1998, the German Narcotics Act was changed to allow the specially licensed methadone-prescribing physician to prescribe so-called 'take-home doses' for up to 7 days under certain conditions. These 'take-home doses' can be taken by the patient without supervision. The intent of this policy is to support and strengthen the rehabilitation of a responsible patient in the course of treatment. Using this strategy, it is hoped that the patient will learn to take control of his addiction and will take the medication only as a way of preventing withdrawal symptoms.
With the increase in the number of patients who receive substitutes and the introduction of 'take-home doses', the availability of methadone on the black market grew (3) . Intravenous abuse of methadone is not uncommon; we know this from fatal cases where needles with methadone solution were found beside the drug addict (4), other reports from drug-related deaths (5, 6) or reports from the drug scene in Germany (7) Australia (8, 9) and Switzerland (10) .
Substitutes are abused by non-substituted individuals, but also by persons who take part in OMT (3, 7) . Reasons for this substitute consumption as given by the questioned consumers include the lower price of methadone compared with heroin, lack of availability of heroin or inadequate dosage of prescribed opioids (7, 11) . Until now, patients taking part in OMT with 'take-home doses' could not be monitored for the way in which way they administered their substitutes; but information about the route of administration is useful for the attending physicians because it shows whether patients are compliant to the therapy concept. The aim of this study was to assess the actual route of methadone or buprenorphine consumption. This was attempted by the determination of disaccharides as 'marker substances' in the urine of drug addicts.
In Germany, substitutes are available as liquids and tablets. In both medicines, carbohydrates are contained as adjuvant. Table 1 provides an overview of the ingredients of the most common tablets and formulations prescribed as substitutes in Germany. Sucrose is used to increase viscosity in liquid methadone preparations (e.g., L-Polamidon w together with Viskose Grundlo¨sung NRF (contains 22 g sucrose in 100 mL) (12) or with Sirupus Simplex (contains 64 g sucrose in 100 mL), while lactose is needed for pressing tablets (e.g., Methaddict w and Subutex w ). In case of oral ingestion, both disaccharides are catabolized by carbolytic enzymes in the small intestine. Disaccharidases split sucrose into glucose and fructose and lactose into glucose and galactose ( Figure 1 ). These monosaccharides are absorbed into the blood by special monosaccharide transporters (13) (14) (15) . In blood, disaccharidases do not exist. Therefore sucrose and lactose cannot be split apart if substitutes containing disaccharides are injected intravenously. They are assumed to be excreted unchanged in urine. Disaccharides in urine may be used as 'marker substances' for intravenously injected disaccharide containing formulations of methadone and buprenorphine.
Materials and method
Reagents and materials Glucose (Ph. Eur. 6.0), lactose monohydrate (Ph.Eur.6.5) and sucrose (Ph. Eur. 6.3) were purchased from Caelo (Hilden, Germany), Figure 1 . Breakdown of lactose and sucrose by disaccharidases in the brush border membrane in the small intestine into the monosaccharides galactose, glucose, and fructose after oral intake (a). Presumed elimination of unchanged disaccharides after intravenous abuse (b). were purchased from J.T. Baker (Griesheim, Germany).
Standards
Glucose, sucrose, trehalose, fructose and galactose standard solutions (1 mg/mL) were prepared by dissolving 10.0 mg of the respective sugar in 10 mL of distilled water. Xylose standard solution (10 mg/L) was prepared by dissolving 100.0 mg in 10 mL of distilled water. Lactose monohydrate (1 mg/mL) was prepared by dissolving 10.53 mg in 10 mL of distilled water. The standards were stable for at least 6 weeks when stored at 48C.
Specimen collection
The anonymous sample group consisted of 26 subjects aged between 26 and 53 years who self-administered methadone, buprenorphine or heroin intravenously in a drug consumption room called 'Drob Inn', Hamburg, Germany. Users who visited the Drob Inn and intended to consume their drugs intravenously were asked by the staff whether they would be willing to deliver a urine sample for research. Urine samples were obtained 15 -30 min after intravenous administration of the respective drugs. Samples were stored as soon as possible at 48C until they were delivered to our laboratory and stored at 2208C until analysis.
Control group
The control group consisted of 30 healthy subjects (laboratory staff and students) aged between 22 and 54 years who ingested 20 g lactose and 20 g sucrose orally in one dose. Persons included in the control group were known to not be illicit drug consumers. Urine specimens were collected about 30 -40 min after the ingestion of the sugars and additionally about 2-3 h later. All the specimens were stored at 2208C until analysis.
Immunoassays
Urine samples of the intravenous consumer group and the control group were analyzed for the presence of methadone, buprenorphine, opiates, cocaine and benzodiazepines using standard immunoassay screening tests (CEDIA DAU, Thermo Fisher Scientific, Middletown, USA) on a Hitachi 912 automatic analyzer. The samples were also tested for pH and creatinine (Jaffe method).
Sample preparation
After the addition of 20 mL xylose (200 mg/L) and 20 mL trehalose (20 mg/L) as internal standards, 1 mL of urine was precipitated with 2 mL of acetone, vortexed and centrifuged (10 min, 3000 U/min). Supernatant was evaporated to dryness by vacuum centrifugation for 90 min at 508C and 2 mbar. Derivatization was performed by ultrasonication for 1 h at 608C after addition of 0.5 mL of 5 M sodium hydroxide and 50 mL of benzoyl chloride to the residue. A liquid -liquid extraction of derivatized carbohydrates was performed with 2 mL of n-pentane. The n-pentane phase was evaporated to dryness under a stream of nitrogen (at 408C) and reconstituted in 0.1 mL of methanol. An aliquot of 30 mL was injected into the HPLC system.
HPLC analysis
Analysis of the extracts was performed on a Thermo HPLC-DAD system using a Thermo UV 6000 detector, Spectra Phoresis SN 4000 interface, a Thermo Spectra System P 4000 pump and a Merck Hitachi AS 2000 autosampler, software Chromquest 4.2.32 version 3.1.6. The benzoylated carbohydrates were separated on a Varian Polaris 5 C18 250 Â 4.0 mm column at a flow rate of 1.0 mL/min and a detection wavelength 230 nm. The mobile phase was composed of acetonitrile, water and tert-butyl-methyl ether (60:24:8).
Validation
The HPLC-DAD method was fully validated according to the GTFCh Guidelines (16), using the Valistat 2.0 statistics program (17) . In order to evaluate method selectivity, blank urine samples from six different sources were prepared as described, but without adding any analyte or internal standards. Furthermore, blank samples containing only the internal standards were extracted and analyzed. When analyzing urine samples spiked with opioids (methadone and buprenorphine), benzodiazepines (diazepam, flunitrazepam and clonazepam) and opiates (morphine and codeine, 6-monoacetylmorphine), no interferences were found.
Calibration was performed by linear regression analysis of arearatio (disaccharides/trehalose) to the calibrator concentration. A 7-point calibration curve was prepared using 1-100 mg/L concentrations of sucrose and lactose in blank urine (calibrators: 1, 5, 10, 20, 50, 70, 100 mg/L). Three quality control samples (8, 40 and 80 mg/L) were analyzed in duplicate over eight days. These samples were used to determine accuracy, precision and reproducibility. The spiked urine samples were stored for 1, 3, 7 and 10 days at 2208C, 48C or 208C to assess storage stability. Furthermore blank urine samples with 40 mg/L galactose, fructose and glucose were prepared and analyzed to obtain knowledge about possible interferences by monosaccharides. It was thought that the possibility might exist that monosaccharides could play a role in case of decomposition of the disaccharides.
Results

Validation results
The method for analysis of disaccharides in urine was developed and validated. This was quite difficult because of the need to isolate hydrophilic analytes out of a hydrophilic matrix. By doing the derivatization step first and then following it with the extraction, the analysis was finally successful. The benzoylated carbohydrates sucrose, lactose, glucose and galactose were extracted, separated and detected by HPLC-DAD. Figure 2 shows a typical chromatogram with detected disaccharides and monosaccharides.
The calibration curves fitted to a linear regression function with r 2 . 0.99; inter-and intra-day imprecision was less than +15%. Further validation results are shown in Table 2 . Storage experiments showed the disaccharides to be stable in urine at 2208C. No monosaccharides were detectable even after a storage period of 10 days. At 48C the disaccharides showed a decline of about 17% (sucrose) and 43% (lactose) within 10 days. At 208C sucrose was reduced by 24% and lactose even by 57% (Figure 3) . After storage at 48C and 208C, monosaccharides were detectable in the disaccharide-spiked samples.
Analysis of urine samples of intravenous drug abusers and control group
After successful method validation, the urine samples of the control group were analyzed. No disaccharides, no monosaccharides and no drugs of abuse were detected in the urine samples of the persons of the control group who ingested disaccharides orally. The method was then applied to the quantitative analysis of sucrose and lactose in urine samples of known drug addicts who consumed drugs of abuse or substitutes intravenously. We obtained these samples from a drug consumption room, called Drob Inn. It is an institution where drug addicts may take their drugs under some kind of supervision combined with the offer of medical or psychosocial support. Drug consumption rooms aim to reduce the presence of high-risk drug use in the public eye. Immunological analysis of the urine samples of the intravenous substitute abusers showed positive results for methadone (53.8%), opiates (53.8%), benzodiazepines (50%), cocaine (69%) and buprenorphine (38.5%). No sample was negative. The majority of samples (76.9%) were positive for two or more parameters. Table 3 gives the detailed results. In all samples, creatinine and pH values were found to be in a physiological range.
All the urine samples were tested positive for lactose or sucrose. In 23.1% of specimens only sucrose was detected, while lactose alone was found in 26.9% of the analyzed samples. Both disaccharides were positive in 50% of the cases. Detailed quantitative results for the disaccharides in combination with immunochemical results are given in Table 4 . Both disaccharides were found in a concentration range from 1.5 mg/L to .100 mg/L. Most of the samples showed results .50 mg/L. 
Discussion
The results show the developed method to be suitable for the detection of carbohydrates in urine. Sucrose and lactose can be determined simultaneously. The monosaccharides, galactose and glucose, can chromatographically be separated and detected, but it was not possible to detect fructose in an adequate manner. Therefore, a complete validation for monosaccharides was not performed, only qualitative analysis was done. Storage experiments had shown the disaccharides to be stable at 2208C for 10 days. In these samples no monosaccharides were detectable even after storage of 10 days. After storage at 48C and 208C, monosaccharides were detectable in the samples. The detectability of monosaccharides in all samples is, therefore, to be assumed by the degradation of disaccharides. Actually, there was no urine Table II . Evaluation data of sucrose and lactose in urine including intra-day precision (CV%, n ¼ 6), inter-day precision (CW%, n ¼ 6), accuracy (%, n ¼ 6) and recovery sample from the intravenous consuming drug users containing no monosaccharides. The sample-taking procedure can explain these positive results. The samples were collected in the drug consumer room and were then stored by the staff at 48C as soon as possible. Until the samples could be stored at 2208C in our lab, a time span of 8-48 h passed. Unfortunately, it was not possible to deep freeze the urine samples in the consumer room. All urine samples of the intravenous drug consumer group had positive findings for disaccharides after the injection of the substitutes, whereas all samples from the control group showed negative results for disaccharides and monosaccharides after oral consumption of a higher dose of both disaccharides. Positive results for carbohydrates are, therefore, not to be anticipated in healthy persons after oral ingestion. These results suggest that the method is useful for distinguishing between an intravenous and an oral use of substitutes. Certainly, in case of intestinal diseases such as ulcerative colitis or Crohn's disease, this method might not be applicable, because the mucosal barrier is inadequate and intact disaccharides can be absorbed from the small intestine (13, 14) .
The detection of sucrose alone (42.9% of methadone positive specimens) suggests the intravenous abuse of liquid methadone formulations which contain only sucrose (and no lactose) as a viscosity enhancer. We checked the declarations of many tablets as given by the manufacturer and all of them contained only lactose. The only exception was Methaddict w . Methaddict w tablets contain lactose and a small amount of sucrose. The detection of big amounts of lactose and small amounts of sucrose in urine, therefore, strongly suggests the intravenous application of Methaddict w tablets. Some consumers prefer tablets due to their known fixed methadone content per tablet (7) . It has to be kept in mind that the sample group did not consist of substituted patients. Actually, we do not know where the consumers obtained their methadone and buprenorphine, but it is astonishing that 23 out of 26 intravenous drug abusers consumed substitutes and only 14 persons opiates. As was shown by the immunochemical results, the sample group consists of polyvalent multi-drug abusers. Not only methadone, but opiates, benzodiazepines and cocaine were found. Other drugs of abuse were not tested. Therefore, the results for disaccharides as markers for intravenous methadone abuse can be influenced by additional intravenous intake of opiates or benzodiazepines. One sample showed only opiates and benzodiazepines to be positive and lactose alone. Street heroin is often blended with lactose and benzodiazepine tablets contain lactose as well. Substituted patients are not allowed to consume opiates or benzodiazepines intravenously in addition to their methadone therapy. Therefore, this should present no problem when substituted patients without parallel consumption of other drugs are tested for disaccharides during a compliance control.
The results of this study reveal that intravenous use of substitutes like methadone and buprenorphine takes place and has to be addressed by the attending doctors and therapists. Intravenous substitute users blog in internet platforms that it is unproblematic to inject methadone tablets dissolved in water or liquids, even those with viscosity enhancers, directly. Some doctors might not be aware of the fact that patients do indeed inject those partially colored viscous liquids.
The established method might also be useful for assessing drug-related deaths. An intravenous application of methadone or buprenorphine results in a higher toxicity due to the fast initial accumulation in brain opiate receptors. Further investigation is Table IV . Immunochemical results and results for disaccharides in urine samples; cutoff concentration: buprenorphine 5 ng/mL, methadone 200 ng/mL, opiates 200 ng/mL and benzodiazepines 200 ng/mL necessary to adapt the method for a detection of carbohydrates in postmortem urine and blood samples.
A more detailed study is in progress to assess the length of time disaccharides are detectable in urine after consumption. Most of the samples showed high concentrations (.50 mg/L sucrose and/or lactose). It is, therefore, anticipated that detection can be achieved for several hours after consumption.
Conclusion
Substitution medicines like methadone and buprenorphine are abused intravenously in the drug scene. Disaccharides were shown to be appropriate specific markers to identify an intravenous uptake of disaccharides via lactose-containing buprenorphine or methadone tablets or sucrose-containing liquids with methadone. The method is a suitable complement to routine screening for drugs of abuse if methadone-prescribing physicians suspect that their patients are abusing the substitutes intravenously. Furthermore, such determinations might be helpful in assessing drug-related deaths because the intravenous application is associated with a higher risk of fatal respiratory depression.
